Update on the management of febrile neutropenia in hematologic patients

• Autores: Francesc Escrihuela Vidal, Júlia Laporte, Adaia Albasanz Puig, Carlota Gudiol González
• Localización: Revista Española de Quimioterapia, ISSN-e 0214-3429, Vol. 32, Nº Extra 2 (September 2019, Suppl.2), 2019, págs. 55-58
• Idioma: inglés
• Enlaces
  • Texto completo (pdf)
• Resumen

  • Febrile neutropenia is a common complication in patients with hematologic malignancies receiving chemotherapy, and is associated with high morbidity and mortality. Infections caused by multidrug-resistant bacteria represent a therapeutic challenge in this high-risk patient population, since inadequate initial empirical antibiotic treatment can seriously compromise prognosis. Besides, reducing antimicrobial exposure is a cornerstone in the fight against resistance